Philippe Giron

Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib

Amir Noeparast, Erik Teugels, Philippe Giron et al. · Oncotarget · 2016 · 100 citations · Full text

Braf Kinase Activity, Impaired Braf Kinases, Pathology +17

Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2

Zhuo Ren, Joeri L. Aerts, Hugo Vandenplas et al. · Cell Death and Disease · 2016 · 46 citations · Full text

Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer

Amir Noeparast, Philippe Giron, Sylvia De Brakeleer et al. · Oncotarget · 2018 · 31 citations · Full text

USP13 controls the stability of Aurora B impacting progression through the cell cycle

Mara Esposito, H. Begum Akman, Philippe Giron et al. · Oncogene · 2020 · 31 citations

Cell Regulation, Cell Division, Cell Signaling +7

CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition

Amir Noeparast, Philippe Giron, Alfiah Noor et al. · Oncogene · 2019 · 29 citations · Full text